Multiple Myeloma: A Case Report

Authors

DOI:

https://doi.org/10.26871/ceus.v8i2.313

Keywords:

Multiple myeloma, plasmacytoma, bone marrow transplant

Abstract

Introduction: Multiple myeloma is a type of plasma cell neoplasm characterized by the production of monoclonal immunoglobulins. Treatment relies on immunomodulators, proteasome inhibitors, antibodies, and steroids; if these fail, an autologous hematopoietic stem cell transplant may be required.

 

Clinical Case: A 60-year-old patient presented with back pain. A CT scan revealed lytic bone lesions throughout the skeleton and a left-sided dorsal tumor. Bone marrow analysis showed elevated beta-2 microglobulin, and a biopsy of the dorsal tumor confirmed a plasmacytoma. The patient was diagnosed with multiple myeloma and treated with eight cycles of the CTD regimen (cyclophosphamide, thalidomide, and dexamethasone) and 30 Gy of radiotherapy. Due to a persistent increase in clonal plasma cells, the treatment was switched to the VTD regimen (bortezomib, thalidomide, and dexamethasone) for eight cycles, followed by a successful allogeneic bone marrow transplant.

 

Conclusions: Multiple myeloma is a relatively common hematologic neoplasm that should be suspected in patients over 60 years of age presenting with multiple lytic lesions associated with chest wall tumors, as seen in this case.

Downloads

Download data is not yet available.

References

1. Kumar V, Abbas AK, Aster JC. Robbins y Cotran Patología Estructural y Funcional. 10ª ed. Barcelona: Elsevier; 2021.

2. Padala SA, Barsouk A, Barsouk A, Rawla P, Vakiti A, Kolhe R, Kota V, Ajebo GH. Epidemiology, Staging, and Management of Multiple Myeloma. Med Sci (Basel) [Internet]. 2021 [citado 12 Oct 2025]; 9(1):3. Disponible en: https://doi.org/10.3390/medsci9010003

3. Berenson JR. Multiple Myeloma. En: MSD Manual Versión para Profesionales [Internet]. Kenilworth (NJ): Merck & Co.; 2024 Ago [citado 12 Oct 2025]. Disponible en: https://www.msdmanuals.com/professional/hematology-and-oncology/plasma-cell-disorders/multiple-myeloma

4. Norris TL. Porth. Fisiopatología: alteraciones de la salud, conceptos básicos. 10ª ed. Filadelfia: Wolters Kluwer; 2018.

5. Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editores. Harrison. Principios de Medicina Interna. 21ª ed. México D.F.: McGraw-Hill Interamericana; 2022.

6. Albagoush SA, Shumway C, Azevedo AM. Multiple Myeloma. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [Actualizado 30 Ene 2023; citado 12 Oct 2025]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK534764/

7. Kumar SK, Beksac M, Dimopoulos MA, Anderson KC, Durie B, San-Miguel J, et al. International Myeloma Working Group consensus response assessment criteria and diagnostics updates for multiple myeloma. Lancet Oncol. 2025; 26(9):e412-24.

8. International Myeloma Working Group Bone Working Group. Clinical practice recommendations for the management of multiple myeloma-related bone disease: 2025 policy review update. Lancet Haematol. 2025; 12(2):e115-26

Published

2026-09-10

How to Cite

Aguirre Tola, L. F., Buñay Avila, A. C., Chacon Alvarez, A. C., & Pinos Vélez, N. C. (2026). Multiple Myeloma: A Case Report. CEUS Scientific Journa, 8(2). https://doi.org/10.26871/ceus.v8i2.313

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.